Role of p73 in malignancy: tumor suppressor or oncogene? (Q34541091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Role of p73 in malignancy: tumor suppressor or oncogene? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

author name string

B M Pützer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

237-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11886306 AND SRC:MED&resulttype=core&format=json

7 December 2019

cites work

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

A new human p53 homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

P63 and P73: P53 mimics, menaces and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

An anti-apoptotic role for the p53 family member, p73, during developmental neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Analysis of p73 in human borderline and invasive ovarian tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Comparative analysis of p73 and p53 regulation and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Identification and classification of p53-regulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Tumor spectrum analysis in p53-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Fine mapping of distal 1p loci reveals TP73 at D1S468.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Tumor surveillance via the ARF-p53 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Mdm2 binds p73 alpha without targeting degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Role of the p53-homologue p73 in E2F1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Role for the p53 homologue p73 in E2F-1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

Lack of p73 expression in mature B-ALL and identification of three new splicing variants restricted to pre B and C-ALL indicate a role of p73 in B cell ALL differentiation

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

Promoter specificity and stability control of the p53-related protein p73

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

Wild type p73 overexpression and high-grade malignancy in breast cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021

Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4400995

7 January 2021